Archives

by in
Entry Author Date Location
East Coast Life Sciences Roundup: Dunsire, Good Start, Nimbus, & More 05/10/13 Boston
Aileron Secures Funding for First Stapled Peptide Clinical Trial 01/14/13 Boston
Aileron Therapeutics Garners $12,000,000 Series D Financing 01/14/13 Boston
Aileron Expands Roche Deal, Agios Gets $78M, Genzyme MS Drug Advances, & More Boston-Area Life Sciences News 11/18/11 Boston
Aileron CEO Hails Expanded Roche Deal as a Validation of Stapled-Peptide Drug Technology 11/17/11 Boston
Atlas and Monsanto the Latest VC and Big Co. Getting Close 04/14/11 Boston
Bill Gates Backs Nimbus, Betting on Computer-Based Drug Discovery 03/10/11 Boston
Aveo Gets Money from OSI, Merck Buys SmartCells, Glaxo Cancels Resveratrol Drug Trial, & More Boston-Area Life Sciences News 12/03/10 Boston
Heartland Reaps $20M, CloudBees Gathers $4M, Adimab Acquires $4M, & More Boston-Area Deals News 12/01/10 Boston
Aileron and Scripps Ink Deal 11/30/10 Boston
MedNetworks Partners with Healthways, NKT Gets $4M, Aileron Lands Deal With Roche, & More Boston-Area Life Sciences News 08/27/10 Boston
Anchor Sinks $10M Series B, Aileron Lands Deal with Roche, C Change Launches Fund With Vanterra, & More Boston-Area Deals News 08/25/10 Boston
Aileron Inks Deal with Roche, Worth Up to $1.1B, to Develop Stapled Peptide Drugs 08/24/10 Boston
Christoph Westphal Resigns as Sirtris CEO, Takes Over Glaxo’s SR One Venture Arm 04/21/10 Boston
2009′s Top 10 Private Equity Deals in Massachusetts: The List 01/25/10 Boston
Excel Venture Management, Starting With Clean Slate, Shows Early Returns on Broad Vision 01/13/10 Boston
Ironwood Nabs $75M in Deal With Japanese Firm, Gloucester Drug Gets FDA Approval, Alnylam Branches Into Biomanufacturing Tech, & More Boston-Area Life Sciences News 11/13/09 Boston
Aileron’s New Class of Drugs Shown to Get Inside Cells to Block Prime Cancer Target 11/11/09 Boston
Build it Boldly, and Pharma Will Come—and More Wisdom from Boston’s Biotech and Pharma Elite at Xconomy Forum 11/05/09 Boston
Why is Pharma Betting So Big on Innovation in Boston? 10/27/09 Boston
New England Venture Activity Rebounds Slightly in Q2—Region’s Top 10 Deals List 07/21/09 Boston
Massachusetts Startup Fundraising Tallied $145M in June—Early Stage Venture Holds Its Own 07/09/09 Boston
Excel Venture Unveils $125M Fund to Make Life Sciences Ideas Cross Over to IT, Energy 07/07/09 Boston
Aileron Piles on $40M, GenArts Lights Up Lucasfilm’s Screens, Taris Takes on $15M, & More Boston-Area Deals News 06/12/09 Boston
Icahn Bags Two Biogen Board Seats, Pharma Giants Add $40M to Aileron Coffers, Pulmatrix Proceeds With Tests of Flu-Blocking Aerosol, & More Boston-Area Life Sciences News 06/10/09 Boston
Aileron Snags $40M From Quartet of Pharma Giants to Develop New Class of Drugs 06/08/09 Boston
Shire Settles TKT Suit, Roche and Ensemble Together Again, BSX Backs Neuromodulation Startup, & More Boston-Area Life Sciences News 11/13/08 Boston
A Lawsuit for Biogen, A Suitor for Millennium, The Suits Who Made Their Own Fate, & More Life Sciences News 04/16/08 Boston
Aileron Raises $10 Million 04/15/08 Boston
Page 1 of 1

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
  2. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  3. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  4. Zillions of Biotech Conferences Want You. Which Should You Attend?
  5. Announcing Xconomy Napa Summit 2013: New Rules for Growth

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.